BLU2864

DESCRIPTION

BLU2864 is an orally active, highly selective, ATP-competitive PRKACA inhibitor with an IC50 of 0.3 nM, exhibiting anti-tumor activity and potential applications in cancer and polycystic kidney disease research [1] [2].

DETAILS

Cas: 2810747-89-6
Purity: 99.42%
Smiles: N(C(=O)C=1C=CC(=NC1)C2=C3C(NC=C3C)=NC=C2)[C@@H]4C=5C(=CC(C(F)F)=CC5F)C[C@@H]4O
Category: Compound
Molecular Weight: 452.43
Molecular Formula: C24H19F3N4O2

Lead Time: < 1 week